Clinical Chemistry and Laboratory Medicine celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2

J Favresse, J Douxfils, B Henry, G Lippi… - Clinical Chemistry and …, 2023 - degruyter.com
This review is an integral part of the special issue for the 60 years of the journal Clinical
Chemistry and Laboratory Medicine (CCLM). The aim of the review is to highlight the role of …

Antibody responses to BNT162b2 vaccination in Japan: monitoring vaccine efficacy by measuring IgG antibodies against the receptor-binding domain of SARS-CoV-2

H Fujigaki, Y Yamamoto, T Koseki, S Banno… - Microbiology …, 2022 - Am Soc Microbiol
To fight severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes
coronavirus disease 2019 (COVID-19), mass vaccination has begun in many countries. To …

Human coronaviruses: counteracting the damage by storm

D Schoeman, BC Fielding - Viruses, 2021 - mdpi.com
Over the past 18 years, three highly pathogenic human (h) coronaviruses (CoVs) have
caused severe outbreaks, the most recent causative agent, SARS-CoV-2, being the first to …

SARS CoV-2 infection among Healthcare Workers from different public health units in Brazil

E Fátima de Cássia, MFS Silva… - Molecular …, 2023 - Elsevier
Understanding COVID-19 exposure differences among Healthcare Workers (HCWs) across
various healthcare units is crucial for their protection and effective management of future …

Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response

YV Zhang, A Kumanovics, J Wiencek, SEF Melanson… - Viruses, 2024 - mdpi.com
This study aimed to evaluate and compare the performance of three anti-S and one anti-N
assays that were available to the project in detecting antibody levels after three commonly …

Medium-to-long-term immunogenicity of BNT162b2 mRNA COVID-19 vaccine: a retrospective cohort study

FP Bianchi, P Stefanizzi, CA Germinario, G Migliore… - Vaccines, 2022 - mdpi.com
To deal with the COVID-19 pandemic, a mass vaccination campaign was started in
European countries on 27 December 2020. The first vaccine available to immunize …

SARS-CoV-2 antibody assay after vaccination: one size does not fit all

M Plebani, C Cosma, A Padoan - Clinical Chemistry and Laboratory …, 2021 - degruyter.com
We read with interest the article of Salvagno and colleagues on anti-SARS-CoV-2
antibodies response after BNT162b2 (Comirnaty Biontech/Pfizer) COVID-19 (coronavirus …

[PDF][PDF] Cat-scratch disease: Experience in a tertiary care children's hospital

I María, EI Bagnaraa, A Buchovskyb - Arch Argent Pediatr, 2023 - sap.org.ar
Introduction. Bartonella henselae is the etiologic agent in cat-scratch disease. It affects
children and young adults. The clinical spectrum is wide; the most common clinical …

COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center

CM Ciniselli, M Lecchi, M Figini, CC Melani… - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 pandemic still represents a global public health emergency,
despite the availability of different types of vaccines that reduced the number of severe …

[PDF][PDF] SARS-CoV-2 antibodies among health care workers from a children's hospital

A Svartza, MJ Riala, C Insúab, G Stedileb… - Arch Argent …, 2023 - sap.org.ar
ABSTRACT Introduction. In Argentina, health care workers have been the first ones to
receive the COVID-19 vaccine, but there are still few data on the production of anti-S IgG …